[1. Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62:D34-D41.10.1016/j.jacc.2013.10.02924355639]Search in Google Scholar
[2. Chaisson NF, Hassoun PM. Systemic sclerosis-associated pulmonary arterial hypertension. Chest. 2013;144:1346-1356.10.1378/chest.12-2396378792024081346]Search in Google Scholar
[3. Tedford R, Mudd J, Girgis R, et al. Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension. Circ Heart Fail. 2013;6:953-963.10.1161/CIRCHEARTFAILURE.112.000008381569723797369]Search in Google Scholar
[4. Nguyen C, Bérezné A, Baubet T, et al. Association of gender with clinical expression, quality of life, disability, and depression and anxiety in patients with systemic sclerosis. PLoS One. 2011;6:e17551.10.1371/journal.pone.0017551305231921408076]Search in Google Scholar
[5. Le Pavec J, Humbert M, Mouthon L, Hassoun PM. Systemic sclerosis-associated pulmonary arterial hypertension. Am J Respir Crit Care Med. 2010;181:1285-1293.10.1164/rccm.200909-1331PP289440720194816]Search in Google Scholar
[6. Ryan JJ, Thenappan T, Luo N, et al. The WHO classification of pulmonary hypertension: A case-based imaging compendium. Pulm Circ. 2012;2:107-121.10.4103/2045-8932.94843334273922558526]Search in Google Scholar
[7. Ferri C, Giuggioli D, Sebastiani M, Colaci M, Emdin M. Heart involvement and systemic sclerosis. Lupus. 2005;14:702-707.10.1191/0961203305lu2204oa16218471]Search in Google Scholar
[8. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360:1989-2003.10.1056/NEJMra080618819420368]Search in Google Scholar
[9. Fernandes F, Ramires FJ, Arteaga E, et al. Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study. J Card Fail. 2003;9:311-317.10.1054/jcaf.2003.5113680552]Search in Google Scholar
[10. Plazak W, Zabinska-Plazak E, Wojas-Pelc A, et al. Heart structure and function in systemic sclerosis. Eur J Dermatology. 2002;12:257-262.]Search in Google Scholar
[11. Lindqvist P, Caidahl K, Neuman-Andersen G, et al. Disturbed right ventricular diastolic function in patients with systemic sclerosis. A Doppler tissue imaging study. Chest. 2005;128:755-763.10.1378/chest.128.2.75516100164]Search in Google Scholar
[12. Durmus E, Sunbul M, Tigen K, et al. Right ventricular and atrial functions in systemic sclerosis patients without pulmonary hypertension: speckle-tracking echocardiographic study. Herz. 2014;40:709-715.10.1007/s00059-014-4113-2]Search in Google Scholar
[13. Hirooka K, Naito J, Koretsune Y, et al. Analysis of transmural trends in myocardial integrated backscatter in patients with progressive systemic sclerosis. J Am Soc Echocardiogr. 2003;16:340-346.10.1016/S0894-7317(02)74427-1]Search in Google Scholar
[14. D’Angelo WA, Fries JF, Masi AT, et al. Pathological observations in systemic sclerosis (scleroderma): A study of 58 autopsy cases and 58 matched controls. Am J Med. 1969;46:428-440.10.1016/0002-9343(69)90044-8]Search in Google Scholar
[15. Gaasch W, Zile M. Left Ventricular Diastolic Dysfunction and Diastolic Heart Failure. Annual Review of Medicine. 2004;55:373-394.10.1146/annurev.med.55.091902.104417]Search in Google Scholar
[16. Allman K, Shaw L, Hachamovitch R, Udelson J. Myocardial Viability Testing and Impact of Revascularization on Prognosis in Patients With Coronary Artery Disease and Left Ventricular Dysfunction: A Meta-Analysis. J Am Coll Cardiol. 2002;39:1151-1158.10.1016/S0735-1097(02)01726-6]Search in Google Scholar
[17. Beller GA. Noninvasive assessment of myocardial viability. N Engl J Med. 2000;343:1488-1490.10.1056/NEJM20001116343201111078777]Search in Google Scholar
[18. Bulkley BH, Ridolfi RL, Salyer WR, et al. Myocardial lesions of progressive systemic sclerosis, a cause of cardiac dysfunction. Circulation. 1976;53:483-490.10.1161/01.CIR.53.3.483]Search in Google Scholar
[19. Armstrong GP, Whalley GA, Doughty RN, et al. Left ventricular function in scleroderma. Br J Rheumatol. 1996;35:983-988.10.1093/rheumatology/35.10.9838883437]Search in Google Scholar
[20. Candell-Riera J, Armadans-Gil L, Simeon CP, et al. Comprehensive noninvasive assessment of cardiac involvement in limited systemic sclerosis. Arthritis Rheum. 1996;39:1138-1145.10.1002/art.17803907108670322]Search in Google Scholar
[21. Turiel M, Gianturco L, Ricci C, et al. Silent cardiovascular involvement in patients with diffuse systemic sclerosis: a controlled cross-sectional study. Arthritis Care Res (Hoboken). 2012;65:274-280.10.1002/acr.2181922899452]Search in Google Scholar
[22. Fernandes F, Ramires FJ, Arteaga E, Ianni BM, Bonfa ES, Mady C. Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study. J Card Fail. 2003;9:311-317.10.1054/jcaf.2003.51]Search in Google Scholar
[23. Kahan A, Allanore Y. Primary myocardial involvement in systemic sclerosis. Rheumatology. 2006;45:iv14-iv17.10.1093/rheumatology/kel312]Search in Google Scholar
[24. Wang M, Yip GW, Wang AY, et al. Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol. 2003;41:820-826.10.1016/S0735-1097(02)02921-2]Search in Google Scholar
[25. De Groote P, Gressin V, Hachulla E, et al. Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis. Ann Rheum Dis. 2008;67:31-36.10.1136/ard.2006.05776017267515]Search in Google Scholar
[26. Olivotti L, Cosmi D, Nicolino A, Martinelli L, Moshiri S, Danzi GB. Large Left Ventricular Aneurysm and Multifocal Myocardial Involvement in a Patient with Systemic Sclerosis. Can J Cardiol. 2017;33:950.e5-950.e6.10.1016/j.cjca.2017.03.01728668148]Search in Google Scholar
[27. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr. 2009;10:165-193.10.1093/ejechocard/jep00719270053]Search in Google Scholar
[28. Hinchcliff M, Desai CS, Varga J, Shah SJ. Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis. Clin Exp Rheumatol. 2012;30:S30-S37.]Search in Google Scholar
[29. Meune C, Vignaux O, Kahan A, Allanore Y. Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies. Archives of Cardiovascular Diseases. 2010;103:46-52.10.1016/j.acvd.2009.06.00920142120]Search in Google Scholar
[30. Yiu KH, Schouffoer AA, Marsan NA. Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis: relationship to functional capacity and ventricular arrhythmias. Arthritis Rheum. 2011;63:3969-3978.10.1002/art.3061422127711]Search in Google Scholar
[31. Meune C, Avouac J, Wahbi K, et al.Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients. Arthritis Rheum. 2008;58:1803-1809.10.1002/art.2346318512815]Search in Google Scholar